Diffuse Large B Cell Lymphomas
Mostrando 1-12 de 43 artigos, teses e dissertações.
-
1. Peritoneal lymphomatosis. A case report
ABSTRACT Introduction: Involvement of the peritoneum occurs very rarely and is exceptional as an exclusive extranodal presentation of lymphomas. In most cases lymphomas associated with this rare entity are high-grade ones. PL secondary to high-grade nodal lymphoma is more frequent than primary peritoneal lymphoma, and there are only a few cases of the latte
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
2. Double or triple-expressor lymphomas: prognostic impact of immunohistochemistry in patients with diffuse large B-cell lymphoma
Mid-Infrared absorption spectroscopy associate with the Partial Least Squares regression is the official method to monitor Brazilian commercial diesel quality. This method, however, uses solvents and a large number of samples for the construction of the calibration curves, which generates waste and increases the time needed for the analysis. In order to deve
Hematol., Transfus. Cell Ther.. Publicado em: 2020-06
-
3. Prognostic impact of MYD88 mutation, proliferative index and cell origin in diffuse large B cell lymphoma
Abstract Background Diffuse large B-cell lymphoma, among non-Hodgkin lymphomas, is one of the most frequent subtypes. Clinical laboratory data and post-treatment outcomes are scarce in the Brazilian population. Objective The main objective of this retrospective study was to assess the impact of tumor markers, including the Myeloid differentiation primary r
Hematol., Transfus. Cell Ther.. Publicado em: 15/04/2019
-
4. Clinical and pathological aspects of bovine lymphoma affecting the spinal cord
RESUMO: Os aspectos clínicos e patológicos do linfoma bovino afetando a medula espinhal foram avaliados através de um estudo retrospectivo dos protocolos de necropsia durante o período de 2005-2017. De um total de 34 bovinos com linfoma, 24 apresentaram afecção do sistema nervoso central (SNC) restrito a medula espinhal. Todos os bovinos afetados eram
Pesq. Vet. Bras.. Publicado em: 2019-01
-
5. Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms
Abstract Background Distinction between mature B-cell neoplasms can be difficult due to overlapping of immunologic features and clinical manifestations. This study investigated whether quantifying mean fluorescence intensity of four monoclonal antibodies in a flow cytometry panel is useful for the differential diagnosis and characterization of these disorde
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-09
-
6. Methotrexate and etanercept-induced primary cutaneous CD4 positive small/medium-sized pleomorphic T-cell lymphoma
Abstract: Immunosuppressive drugs and biological agents may represent a potential risk of lymphoma development in patients with rheumatoid arthritis. But most cases are diffuse, large B-cell lymphomas. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma, a provisional entity in the 2005 WHO-EORTC classification of cutaneous lymphomas, is on
An. Bras. Dermatol.. Publicado em: 2016-06
-
7. Mature B cell neoplasms: retrospective analysis of 93 cases diagnosed between 2011 and 2014 in a University Hospital in southern Brazil
ABSTRACT BACKGROUND: According to the 2008 World Health Organization classification, mature B-cell neoplasms are a heterogeneous group of diseases that include B-cell lymphomas and plasma cell disorders. These neoplasms can have very different clinical behaviors, from highly aggressive to indolent, and therefore require diverse treatment strategies. OBJECT
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-06
-
8. Primary Extranodal Non-Hodgkin Lymphoma of the Head and Neck in Patients with Acquired Immunodeficiency Syndrome: A Clinicopathologic Study of 24 Patients in a Single Hospital of Infectious Diseases in Argentina
Introduction Extranodal non-Hodgkin lymphomas (NHLs) are commonly described in patients with acquired immunodeficiency syndrome (AIDS) and are related with an atypical morphology and aggressive clinical course. AIDS-associated lymphomas are characterized by their rapid progression, frequent extranodal manifestations, and poor outcome. Objective The aim of
Int. Arch. Otorhinolaryngol.. Publicado em: 2014-09
-
9. Survival in patients with oral and maxillofacial diffuse large B-cell lymphoma
The purpose of this study was to determine the survival and prognostic factors of patients with diffuse large B-cell lymphoma (DLBCL) of the oral cavity and maxillofacial region. Retrospectively, the clinical records of patients with a primary diagnosis of DLBCL of the oral cavity and maxillofacial region treated at the A.C. Camargo Hospital for Cancer, São
Braz. oral res.. Publicado em: 11/06/2013
-
10. The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma
Background: Serum lactate dehydrogenase is a non-specific marker for lymphoma whose prognostic significance is well established for both indolent and aggressive lymphomas at the time of diagnosis. The performance characteristics of this enzyme in predicting relapse in patie
Rev. Bras. Hematol. Hemoter.. Publicado em: 2013-06
-
11. Expression of immunohistochemical markers in patients with AIDS-related lymphoma
AIDS-related lymphomas (ARL) present high biological heterogeneity. For better characterization of this type of lymphoma, the objectives of the present study were to evaluate the expression of immunohistochemical markers of cell differentiation (CD10, Bcl-6, MUM-1) and determine cell origin profile according to Hans' classification of diffuse large B-cell ly
Brazilian Journal of Infectious Diseases. Publicado em: 2012-02
-
12. Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas
OBJECTIVE: To evaluate the use of high-dose sequential chemotherapy in a Brazilian population. METHODS: High-dose cyclophosphamide followed by autologous hematopoietic stem cell transplantation is an effective and feasible therapy for refractory/relapsed lymphomas; this regimen has never before been evaluated in a Brazilian population. All patients (106 with
Revista Brasileira de Hematologia e Hemoterapia. Publicado em: 2011-12